Lilly Covid-19 treatment could be authorised by September: Chief Scientist

Lilly has already launched human trials with two of the experimental therapies

Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday. Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said in an interview.

ALSO READ: Coronavirus LIVE: India sees over 12k cases in a day; tally hits 287,155

Lilly has already launched human trials with two of the experimental therapies. The drugs belong to a class of biotech medicines called monoclonal antibodies widely used to treat cancer, rheumatoid arthritis and many other conditions. A monoclonal antibody drug developed against COVID-19 is likely to be more effective than repurposed medicines currently being tested against the virus. Skovronsky said the therapies – which may also be used to prevent the disease – could beat a vaccine to widespread use as a COVID-19 treatment, if they prove effective…Read More

PM Modi to address 95th annual plenary session of Chamber of Commerce today

Earlier on June 2, Prime Minister Modi participated in the annual general meeting of Confederation of Indian Industry (CII), the foremost national chamber, through a video conference

Prime Minister Narendra Modi will deliver the inaugural address of the 95th annual plenary session of the Indian Chamber of Commerce (ICC) on Thursday 11 am via video conferencing. Earlier on June 2, Prime Minister Modi participated in the annual general meeting of Confederation of Indian Industry (CII), the foremost national chamber, through a video conference. He had said at the meeting of CII that Indian industries should take advantage of the trust developed towards India as the world is looking for a trusted and reliable partner.

ALSO READ: Who is responsible for Chinese intrusion in eastern Ladakh? Cong asks Modi

Addressing the 125th Annual Session of CII, the Prime Minister said: “World is looking for a trusted, reliable partner. India has potential, strength and ability. Today, Indian industries should take advantage of the trust developed in the world towards India… Getting growth back is not that difficult. The biggest thing is that Indian industries have a clear path of self-reliance.”

He said that the country now needs to manufacture products which are ‘Made in India’ but are ‘Made for the World’. The Prime Minister said that ration has been provided to 74 crore beneficiaries of Pradhan Mantri Garib Kalyan Yojana while adding that ration is also being provided to migrant labourers for free. The live broadcast feed of today’s event will be available from Doordarshan/ANI…

 aaliyag